Gary Safsten – PACCAR Inc

Semi-Annual Medical Device Supplier Quality Conference: Speaker Interview   Gary Safsten Assistant Director of Supplier Quality PACCAR Inc   Gary Safsten is Assistant Director of Supplier Quality with PACCAR, assigned to PACCAR’s North American supply base....

FDA Approves Merck Tumor Treatment for DNA-Linked Cancers

In a move towards general cancer treatment, the FDA has approved Merck’s cancer drug for the treatment of any advanced tumor with microsatellite instability or DNA mismatch repair defects. Variants of these DNA indicators are present in genetically-linked cancers. The...

Mike Kijewski – Medcrypt

2nd Annual Medical Device Cybersecurity Risk Mitigation Conference: Speaker Interview   Mike Kijewski CEO MEDCRYPT   Mike will be one of the distinguished speakers at the 2nd Annual Medical Device Cybersecurity Risk Mitigation Conference. Why is the 2nd...

New Drug Approved for Lou Gehrig’s disease by the FDA

For the first time in nearly two decades, a drug has been approved to treat amyotrophic lateral sclerosis, which is commonly referred to as Lou Gehrig’s disease. The drug, Radicava, is only the second drug to be approved by the FDA for this particular disease. In a...